Extracellular vesicles from a muscle cell line (C2C12) enhance cell survival and neurite outgrowth of a motor neuron cell line (NSC-34)

Journal of Extracellular Vesicles

Volumn 3, Issue 1, 2014, Pages 1-9

  Madison, Roger D ^a,b   McGee, Christopher ^b   Rawson, Renee ^a   Robinson, Grant A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN;

ANIMAL CELL; ARTICLE; C2C12 CELL LINE; CELL ACTIVITY; CELL LINE; CELL SURVIVAL; CELL TRANSPORT; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR VESICLE; MOTONEURON; MUSCLE CELL; MYOTUBE; NERVE FIBER GROWTH; NONHUMAN; NSC 34 CELL LINE; PROTEIN EXPRESSION;

EID: 84923049991     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v3.22865     Document Type: Article

References (48)

1. Frank E, Jansen JK, Lomo T, Westgaard RH. The interaction between foreign and original motor nerves innervating the soleus muscle of rats. J Physiol. 1975;247:725-43.
2. Sanes JR, Lichtman JW. Development of the vertebrate neuromuscular junction. Annu Rev Neurosci. 1999;22:389-442.
3. Wallenius V, Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, et al. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol. 2000;156:821-9.
4. Jennische E, Ekberg S, Matejka GL. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am Phys Soc. 1993;265:122-8.
5. Yamaguchi A, Ishii H, Morita I, Oota I, Takeda H. mRNA expression of fibroblast growth factors and hepatocyte growth factor in rat plantaris muscle following denervation and compensatory overload. Eur J Physiol. 2004;448:539-46.
6. Tonra JR, Curtis R, Wong V, Cliffer KD, Park JS, Timmes A, et al. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J Neurosci. 1998;18:4374-83.
7. Lie D, Weis J. GDNF expression is increased in denervated human skeletal muscle. Neurosci Lett. 1998;250:87-90.
8. Wehrwein EA, Roskelley EM, Spitsbergen JM. GDNF is regulated in an activity-dependent manner in rat skeletal muscle. Muscle Nerve. 2002;26:206-11.
9. Zhao C, Veltri K, Li S, Bain JR, Fahnestock M. NGF, BDNF, NT-3, and GDNF mRNA expression in rat skeletal muscle following denervation and sensory protection. J Neurotrauma. 2004;21:1468-78.
10. Lawoko G, Tagerud S. High endocytotic activity occurs periodically in the endplate region of denervated mouse striated muscle fibers. Exp Cell Res. 1995;219:598-603.
11. Libelius R, Tagerud S. Lysosomes in skeletal muscle. In: Libelius R, Thesleff S, editors. Neuromuscular junction. Amsterdam: Elsevier; 1989. p. 481-5.
12. Thesleff S, Libelius R, Tagerud S. Some aspects of long term regulations of nerve-muscle relations. In: Rose CR, Jones R, Vrbova G, editors. Neuromuscular stimulation: basic concepts and clinical applications. New York: Demos; 1989. p. 27-36.
13. deLapeyriere O, Henderson CE. Motoneuron differentiation, survival and synaptogenesis. Curr Opin Genet Dev. 1997;7: 642-50.
14. Henderson CE, Bloch-Gallego E, Camu W, Gouin A, Lemeulle C, Mettling C, et al. Motoneuron survival factors: biological roles and therapeutic potential. Neuromusc Disord. 1993;3:455-8.
15. Magnusson C, Svensson A, Christerson U, Tagerud S. Denervation-induced alterations in gene expression in mouse skeletal muscle. Eur J Neurosci. 2005;21:577-80.
16. Taylor AR, Gifondorwa DJ, Newbern JM, Robinson MB, Strupe JL, Prevette D, et al. Astrocyte and muscle-derived secreted factors differentially regulate motoneuron survival. J Neurosci. 2007;27:634-44.
17. Vrbova G, Gordon T, Jones R. Nerve regeneration and muscle reinnervation. In: Vrbova G, Gordon T, Jones R, editors. Nerve-muscle interaction. London: Chapman and Hall; 1995. p. 197-235.
18. Witwer KW, Buzas EI, Bemis LT, Bora A, Lässer C, Lö tvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2: 20360. doi: 10.3402/jev.v2i0.20360.
19. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.
20. Van der Vos KE, Balaj L, Skog J, Breakefield XO. Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol. 2011;31:949-59.
21. Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3.
22. Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct. 2007;2:35.
23. Lopez-Verrilli MA, Court FA. Transfer of vesicles from Schwann cells to axons: a novel mechanism of communication in the peripheral nervous system. Front Physiol. 2012;3:1-6.
24. Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, Tibollo P, et al. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res. 2010;316:1977-84.
25. Lopez-Verrilli MA, Picou F, Court FA. Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia. 2013;61:1795-806.
26. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008;8:4083-99.
27. El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc. 2012;7:2112-26.
28. Dehmelt L, Poplawski G, Hwang E, Halpain S. NeuriteQuant: an open source toolkit for high content screens of neuronal morphogenesis. BMC Neurosci. 2011;12:1-13.
29. Madison RD, Robinson GA, Chadaram SR. The specificity of motor neurone regeneration (preferential reinnervation). Acta Physiol Scand. 2007;189:201-6.
30. Madison RD, Archibald SJ, Brushart TM. Reinnervation accuracy of the rat femoral nerve by motor and sensory neurons. J Neurosci. 1996;16:5698-703.
31. Madison RD, Archibald SJ, Lacin R, Krarup C. Factors contributing to preferential motor reinnervation in the primate peripheral nervous system. J Neurosci. 1999;19:11007-16.
32. Madison RD, Sofroniew MV, Robinson GA. Schwann cell influence on motor neuron regeneration accuracy. Neuroscience. 2009;163:213-21.
33. Robinson GA, Madison RD. Manipulations of the mouse femoral nerve influence the accuracy of pathway reinnervation by motor neurons. Exp Neurol. 2005;192:39-45.
34. Uschold T, Robinson GA, Madison RD. Motor neuron regeneration accuracy: balancing trophic influences between pathways and end-organs. Exp Neurol. 2007;205:250-6.
35. Yaffe D, Saxel O. A myogenic cell line with altered serum requirements for differentiation. Differentiation. 1977;7:159-66.
36. Casadei L, Vallorani L, Gioacchini AM, Guescini M, Burattini S, D'Emilio A, et al. Proteomics-based investigation in C2C12 myoblast differentiation. Eur J Histochem. 2009;53:261-8.
37. Fujita H, Endo A, Shimizu K, Nagamori E. Evaluation of serum-free differentiation conditions for C2C12 myoblast cells assessed as to active tension generation capability. Biotechnol Bioeng. 2010;107:894-901.
38. Fujita H, Hirano M, Shimizu K, Nagamori E. Rapid decrease in active tension generated by C2C12 myotubes after termination of artificial exercise. J Muscle Res Cell Motil. 2010;31: 279-88.
39. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194:209-21.
40. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011;6:481-92.
41. Dadon-Nachum M, Sadan O, Srugo I, Melamed E, Offen D. Differentiated mesenchymal stem cells for sciatic nerve injury. Stem Cell Rev. 2011;7:664-71.
42. Dadon-Nachum M, Melamed E, Offen D. Stem cells treatment for sciatic nerve injury. Expert Opin Biol Ther. 2011;11: 1591-7.
43. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res. 2010;4:214-22.
44. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK, et al. Mesenchymal stem cell secretes microparticles enriched in premicroRNAs. Nucleic Acids Res. 2010;38:215-24.
45. Viaud S, Thery C, Ploix S, Tursz T, Lapierre V, Lantz O, et al. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res. 2010;70:1281-5.
46. El Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev. 2013;65:391-7.
47. El Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347-57.
48. Lakhal S, Wood MJ. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays. 2011;33:737-41.